Abstract

One of the critical events that regulates muscle cell differentiation is the replacement of the lamin B receptor (LBR)-tether with the lamin A/C (LMNA)-tether to remodel transcription and induce differentiation-specific genes. Here, we report that localization and activity of the LBR-tether are crucially dependent on the muscle-specific chaperone HSPB3 and that depletion of HSPB3 prevents muscle cell differentiation. We further show that HSPB3 binds to LBR in the nucleoplasm and maintains it in a dynamic state, thus promoting the transcription of myogenic genes, including the genes to remodel the extracellular matrix. Remarkably, HSPB3 overexpression alone is sufficient to induce the differentiation of two human muscle cell lines, LHCNM2 cells, and rhabdomyosarcoma cells. We also show that mutant R116P-HSPB3 from a myopathy patient with chromatin alterations and muscle fiber disorganization, forms nuclear aggregates that immobilize LBR. We find that R116P-HSPB3 is unable to induce myoblast differentiation and instead activates the unfolded protein response. We propose that HSPB3 is a specialized chaperone engaged in muscle cell differentiation and that dysfunctional HSPB3 causes neuromuscular disease by deregulating LBR.

Details

Title
Small heat-shock protein HSPB3 promotes myogenesis by regulating the lamin B receptor
Author
Tiago Tatiana 1   VIAFID ORCID Logo  ; Hummel, Barbara 2 ; Morelli, Federica F 1 ; Basile Valentina 1 ; Vinet, Jonathan 1 ; Galli, Veronica 1 ; Mediani Laura 1 ; Antoniani Francesco 1 ; Pomella Silvia 3   VIAFID ORCID Logo  ; Cassandri Matteo 3 ; Garone Maria Giovanna 4 ; Silvestri Beatrice 5 ; Cimino, Marco 1 ; Cenacchi Giovanna 6   VIAFID ORCID Logo  ; Costa, Roberta 6   VIAFID ORCID Logo  ; Mouly, Vincent 7 ; Poser Ina 8 ; Yeger-Lotem Esti 9   VIAFID ORCID Logo  ; Rosa, Alessandro 5   VIAFID ORCID Logo  ; Alberti, Simon 10   VIAFID ORCID Logo  ; Rota Rossella 3   VIAFID ORCID Logo  ; Ben-Zvi, Anat 11   VIAFID ORCID Logo  ; Sawarkar Ritwick 12 ; Carra Serena 1   VIAFID ORCID Logo 

 University of Modena and Reggio Emilia, Centre for Neuroscience and Nanotechnology, Department of Biomedical, Metabolic and Neural Sciences, Modena, Italy (GRID:grid.7548.e) (ISNI:0000000121697570) 
 Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany (GRID:grid.429509.3) (ISNI:0000 0004 0491 4256) 
 Bambino Gesù Children’s Hospital, IRCCS, Department of Oncohematology, Rome, Italy (GRID:grid.414125.7) (ISNI:0000 0001 0727 6809) 
 Sapienza University of Rome, Department of Biology and Biotechnologies “Charles Darwin”, Rome, Italy (GRID:grid.7841.a) 
 Sapienza University of Rome, Department of Biology and Biotechnologies “Charles Darwin”, Rome, Italy (GRID:grid.7841.a); Fondazione Istituto Italiano di Tecnologia (IIT), Center for Life Nano- & Neuro-Science, Rome, Italy (GRID:grid.7841.a) 
 University of Bologna, IRCCS St. Orsola Hospital, Department of Biomedical and Neuromotor Sciences DIBINEM, University of Bologna, Bologna, Italy; Centre for Applied Biomedical Research - CRBA, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758) 
 Sorbonne Université, Inserm, Institut de Myologie, Centre de Recherche en Myologie, Paris, France (GRID:grid.418250.a) (ISNI:0000 0001 0308 8843) 
 Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany (GRID:grid.419537.d) (ISNI:0000 0001 2113 4567); Dewpoint Therapeutics GmbH, Dresden, Germany (GRID:grid.419537.d) 
 Ben-Gurion University of the Negev, Department of Clinical Biochemistry and Pharmacology and the National Institute for Biotechnology in the Negev, Beer Sheva, Israel (GRID:grid.7489.2) (ISNI:0000 0004 1937 0511) 
10  Technische Universität Dresden, Biotechnology Center (BIOTEC), Center for Molecular and Cellular Bioengineering (CMCB), Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257) 
11  Ben-Gurion University of the Negev, Department of Life Sciences, Beer Sheva, Israel (GRID:grid.7489.2) (ISNI:0000 0004 1937 0511) 
12  Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany (GRID:grid.429509.3) (ISNI:0000 0004 0491 4256); University of Cambridge, Medical Research Council (MRC), Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934) 
Publication year
2021
Publication date
May 2021
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2522498015
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.